Status:
COMPLETED
Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants
Lead Sponsor:
Haiyan Wang
Conditions:
COVID-19 Pandemic
Eligibility:
All Genders
18-70 years
Brief Summary
The goal of this observational study is to retrospectively analyze left atrial function in mild to moderate COVID-19-recovered patients. The main questions it aims to answer are: * Whether left atria...
Detailed Description
The included patients who recovered from COVID-19 infection and healthy people underwent transthoracic echocardiography at the First Affiliated Hospital of Shandong First Medical University from Decem...
Eligibility Criteria
Inclusion
- 1\. Patients having been diagnosed with SARS-CoV-2 Omicron variant infection based on real-time reverse-transcription polymerase chain reaction (RT-PCR) results; 2. Asymptomatic or mild to moderate COVID-19 patients. 3.COVID-19 patients who came to our hospital for echocardiography within 3 months after recovery.
Exclusion
- Patients with decreased left ventricular ejection fraction (less than 50%), left ventricular segmental wall motion abnormalities, cardiomyopathy, severe valvular heart disease, arrhythmia, thyroid dysfunction, pulmonary hypertension, past or current pulmonary embolism, severe chronic obstructive pulmonary disease, malignancy/renal failure (less than 30) ml/min) or poor cardiogram image quality were excluded from the study.
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06170307
Start Date
November 20 2023
End Date
August 20 2024
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China, 250000